DePuy ASR Hip Lawsuit Given Expedited Trial Date in California

|

Although Johnson & Johnson has agreed to pay more than $2.4 billion to settle DePuy ASR hip lawsuits brought throughout the country, a California court has granted a request for an expedited trial date in a case brought by a man suffering from a terminal form of cancer.

In November, a DePuy ASR settlement program was announced by the manufacturer of the controversial metal-on-metal hip replacement system, which may resolve about 8,000 cases for an average payment of about $250,000 per claim.

The offer to resolve cases only applies to claims brought by individuals who underwent hip revision surgery prior to August 31, 2013, due to problems with a DePuy ASR hip. Although plaintiffs are not obligated to accept in the settlement, the deal requires that at least 94% of eligible claimants agree to participate by April 1, 2014, or Johnson & Johnson and their DePuy Orthopaedics subsidiary may back out of the agreement.

"*" indicates required fields

"*" indicates required fields

According to a notice issued by the San Francisco Superior Court on January 10, a trial date will be set within the next 120 days for a lawsuit brought by Gary Darling, whose DePuy ASR hip failed just two years after being implanted. The case is being expedited because he suffers from terminal non-small cell lung cancer.

Darling had the DePuy implanted in October 2008 and began to feel pain in his left hip in the summer of 2010. In July 2011, Darling underwent revision surgery and suffers pain, discomfort and loss of normal range of motion in his left hip, according to a memorandum (PDF) filed on December 27 in support of the request for an expedited trial date in the case.

The brief states that Darling was diagnosed with stage III inoperable lung cancer on February 21, 2012. He is currently receiving hospice care.

While the hip replacement settlement is expected to resolve the majority of claims, it will not end the entire DePuy ASR litigation. Individuals who decline the offer and those who have not had to have their DePuy ASR hip replaced prior to August 2013 will still continue to litigate their claims. In addition, individuals who have their hips fail in the future will be able to seek compensation through new lawsuits.

Prior to the settlement agreement being reached, only two DePuy ASR cases made it to trial nationwide, with aย California jury awarding $8.3 million in damagesย earlier this year and a second trial inย Illinois state court resulting in a defense verdictย weeks later.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

The first Bard PowerPort lawsuit bellwether trial commences next week involving claims that a man suffered a severe infection due to the port catheter’s allegedly defective design.
A Louisiana man’s Boston Scientific WaveWriter Alpha SCS lawsuit claims the implant failed to provide the promised pain relief and, in fact, made things worse before it needed to be surgically removed.